Global Glucagon Market Analysis and Forecast 2024-2030
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
According to APO Research, The global Glucagon market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
This report presents an overview of global market for Glucagon, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Glucagon, also provides the sales of main regions and countries. Of the upcoming market potential for Glucagon, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Glucagon sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Glucagon market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Glucagon sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals and Xeris Pharmaceuticals, etc.
Glucagon segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Glucagon in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucagon sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
According to APO Research, The global Glucagon market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
This report presents an overview of global market for Glucagon, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Glucagon, also provides the sales of main regions and countries. Of the upcoming market potential for Glucagon, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Glucagon sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Glucagon market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Glucagon sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals and Xeris Pharmaceuticals, etc.
Glucagon segment by Company
- Novo Nordisk
- Eli Lilly
- Fresenius Kabi
- Torrent Labs
- Taj Pharmaceuticals
- Xeris Pharmaceuticals
- Inject Glucagon
- Nasal Glucagon
- Emergency Kits
- General Use
- Diagnostic & Motility
- Cardiogenic Shock
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Glucagon in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucagon sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Glucagon Market by Type
1.2.1 Global Glucagon Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon Market by Application
1.3.1 Global Glucagon Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 GLUCAGON MARKET DYNAMICS
2.1 Glucagon Industry Trends
2.2 Glucagon Industry Drivers
2.3 Glucagon Industry Opportunities and Challenges
2.4 Glucagon Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Glucagon Revenue Estimates and Forecasts (2019-2030)
3.2 Global Glucagon Revenue by Region
3.2.1 Global Glucagon Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Glucagon Revenue by Region (2019-2024)
3.2.3 Global Glucagon Revenue by Region (2025-2030)
3.2.4 Global Glucagon Revenue Market Share by Region (2019-2030)
3.3 Global Glucagon Sales Estimates and Forecasts 2019-2030
3.4 Global Glucagon Sales by Region
3.4.1 Global Glucagon Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Glucagon Sales by Region (2019-2024)
3.4.3 Global Glucagon Sales by Region (2025-2030)
3.4.4 Global Glucagon Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Glucagon Revenue by Manufacturers
4.1.1 Global Glucagon Revenue by Manufacturers (2019-2024)
4.1.2 Global Glucagon Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Glucagon Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Glucagon Sales by Manufacturers
4.2.1 Global Glucagon Sales by Manufacturers (2019-2024)
4.2.2 Global Glucagon Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Glucagon Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Glucagon Sales Price by Manufacturers (2019-2024)
4.4 Global Glucagon Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Glucagon Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Glucagon Manufacturers, Product Type & Application
4.7 Global Glucagon Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Glucagon Market CR5 and HHI
4.8.2 2023 Glucagon Tier 1, Tier 2, and Tier
5 GLUCAGON MARKET BY TYPE
5.1 Global Glucagon Revenue by Type
5.1.1 Global Glucagon Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Glucagon Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Glucagon Revenue Market Share by Type (2019-2030)
5.2 Global Glucagon Sales by Type
5.2.1 Global Glucagon Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Glucagon Sales by Type (2019-2030) & (K MT)
5.2.3 Global Glucagon Sales Market Share by Type (2019-2030)
5.3 Global Glucagon Price by Type
6 GLUCAGON MARKET BY APPLICATION
6.1 Global Glucagon Revenue by Application
6.1.1 Global Glucagon Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Glucagon Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Glucagon Revenue Market Share by Application (2019-2030)
6.2 Global Glucagon Sales by Application
6.2.1 Global Glucagon Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Glucagon Sales by Application (2019-2030) & (K MT)
6.2.3 Global Glucagon Sales Market Share by Application (2019-2030)
6.3 Global Glucagon Price by Application
7 COMPANY PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Comapny Information
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Novo Nordisk Glucagon Product Portfolio
7.1.5 Novo Nordisk Recent Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Comapny Information
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Eli Lilly Glucagon Product Portfolio
7.2.5 Eli Lilly Recent Developments
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Comapny Information
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Fresenius Kabi Glucagon Product Portfolio
7.3.5 Fresenius Kabi Recent Developments
7.4 Torrent Labs
7.4.1 Torrent Labs Comapny Information
7.4.2 Torrent Labs Business Overview
7.4.3 Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Torrent Labs Glucagon Product Portfolio
7.4.5 Torrent Labs Recent Developments
7.5 Taj Pharmaceuticals
7.5.1 Taj Pharmaceuticals Comapny Information
7.5.2 Taj Pharmaceuticals Business Overview
7.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
7.5.5 Taj Pharmaceuticals Recent Developments
7.6 Xeris Pharmaceuticals
7.6.1 Xeris Pharmaceuticals Comapny Information
7.6.2 Xeris Pharmaceuticals Business Overview
7.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
7.6.5 Xeris Pharmaceuticals Recent Developments
8 NORTH AMERICA
8.1 North America Glucagon Market Size by Type
8.1.1 North America Glucagon Revenue by Type (2019-2030)
8.1.2 North America Glucagon Sales by Type (2019-2030)
8.1.3 North America Glucagon Price by Type (2019-2030)
8.2 North America Glucagon Market Size by Application
8.2.1 North America Glucagon Revenue by Application (2019-2030)
8.2.2 North America Glucagon Sales by Application (2019-2030)
8.2.3 North America Glucagon Price by Application (2019-2030)
8.3 North America Glucagon Market Size by Country
8.3.1 North America Glucagon Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Glucagon Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Glucagon Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Glucagon Market Size by Type
9.1.1 Europe Glucagon Revenue by Type (2019-2030)
9.1.2 Europe Glucagon Sales by Type (2019-2030)
9.1.3 Europe Glucagon Price by Type (2019-2030)
9.2 Europe Glucagon Market Size by Application
9.2.1 Europe Glucagon Revenue by Application (2019-2030)
9.2.2 Europe Glucagon Sales by Application (2019-2030)
9.2.3 Europe Glucagon Price by Application (2019-2030)
9.3 Europe Glucagon Market Size by Country
9.3.1 Europe Glucagon Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Glucagon Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Glucagon Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Glucagon Market Size by Type
10.1.1 China Glucagon Revenue by Type (2019-2030)
10.1.2 China Glucagon Sales by Type (2019-2030)
10.1.3 China Glucagon Price by Type (2019-2030)
10.2 China Glucagon Market Size by Application
10.2.1 China Glucagon Revenue by Application (2019-2030)
10.2.2 China Glucagon Sales by Application (2019-2030)
10.2.3 China Glucagon Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Glucagon Market Size by Type
11.1.1 Asia Glucagon Revenue by Type (2019-2030)
11.1.2 Asia Glucagon Sales by Type (2019-2030)
11.1.3 Asia Glucagon Price by Type (2019-2030)
11.2 Asia Glucagon Market Size by Application
11.2.1 Asia Glucagon Revenue by Application (2019-2030)
11.2.2 Asia Glucagon Sales by Application (2019-2030)
11.2.3 Asia Glucagon Price by Application (2019-2030)
11.3 Asia Glucagon Market Size by Country
11.3.1 Asia Glucagon Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Glucagon Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Glucagon Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Glucagon Market Size by Type
12.1.1 MEALA Glucagon Revenue by Type (2019-2030)
12.1.2 MEALA Glucagon Sales by Type (2019-2030)
12.1.3 MEALA Glucagon Price by Type (2019-2030)
12.2 MEALA Glucagon Market Size by Application
12.2.1 MEALA Glucagon Revenue by Application (2019-2030)
12.2.2 MEALA Glucagon Sales by Application (2019-2030)
12.2.3 MEALA Glucagon Price by Application (2019-2030)
12.3 MEALA Glucagon Market Size by Country
12.3.1 MEALA Glucagon Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Glucagon Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Glucagon Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Glucagon Value Chain Analysis
13.1.1 Glucagon Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Glucagon Production Mode & Process
13.2 Glucagon Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Glucagon Distributors
13.2.3 Glucagon Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Glucagon Market by Type
1.2.1 Global Glucagon Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon Market by Application
1.3.1 Global Glucagon Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 GLUCAGON MARKET DYNAMICS
2.1 Glucagon Industry Trends
2.2 Glucagon Industry Drivers
2.3 Glucagon Industry Opportunities and Challenges
2.4 Glucagon Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Glucagon Revenue Estimates and Forecasts (2019-2030)
3.2 Global Glucagon Revenue by Region
3.2.1 Global Glucagon Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Glucagon Revenue by Region (2019-2024)
3.2.3 Global Glucagon Revenue by Region (2025-2030)
3.2.4 Global Glucagon Revenue Market Share by Region (2019-2030)
3.3 Global Glucagon Sales Estimates and Forecasts 2019-2030
3.4 Global Glucagon Sales by Region
3.4.1 Global Glucagon Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Glucagon Sales by Region (2019-2024)
3.4.3 Global Glucagon Sales by Region (2025-2030)
3.4.4 Global Glucagon Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Glucagon Revenue by Manufacturers
4.1.1 Global Glucagon Revenue by Manufacturers (2019-2024)
4.1.2 Global Glucagon Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Glucagon Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Glucagon Sales by Manufacturers
4.2.1 Global Glucagon Sales by Manufacturers (2019-2024)
4.2.2 Global Glucagon Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Glucagon Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Glucagon Sales Price by Manufacturers (2019-2024)
4.4 Global Glucagon Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Glucagon Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Glucagon Manufacturers, Product Type & Application
4.7 Global Glucagon Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Glucagon Market CR5 and HHI
4.8.2 2023 Glucagon Tier 1, Tier 2, and Tier
5 GLUCAGON MARKET BY TYPE
5.1 Global Glucagon Revenue by Type
5.1.1 Global Glucagon Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Glucagon Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Glucagon Revenue Market Share by Type (2019-2030)
5.2 Global Glucagon Sales by Type
5.2.1 Global Glucagon Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Glucagon Sales by Type (2019-2030) & (K MT)
5.2.3 Global Glucagon Sales Market Share by Type (2019-2030)
5.3 Global Glucagon Price by Type
6 GLUCAGON MARKET BY APPLICATION
6.1 Global Glucagon Revenue by Application
6.1.1 Global Glucagon Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Glucagon Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Glucagon Revenue Market Share by Application (2019-2030)
6.2 Global Glucagon Sales by Application
6.2.1 Global Glucagon Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Glucagon Sales by Application (2019-2030) & (K MT)
6.2.3 Global Glucagon Sales Market Share by Application (2019-2030)
6.3 Global Glucagon Price by Application
7 COMPANY PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Comapny Information
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Novo Nordisk Glucagon Product Portfolio
7.1.5 Novo Nordisk Recent Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Comapny Information
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Eli Lilly Glucagon Product Portfolio
7.2.5 Eli Lilly Recent Developments
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Comapny Information
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Fresenius Kabi Glucagon Product Portfolio
7.3.5 Fresenius Kabi Recent Developments
7.4 Torrent Labs
7.4.1 Torrent Labs Comapny Information
7.4.2 Torrent Labs Business Overview
7.4.3 Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Torrent Labs Glucagon Product Portfolio
7.4.5 Torrent Labs Recent Developments
7.5 Taj Pharmaceuticals
7.5.1 Taj Pharmaceuticals Comapny Information
7.5.2 Taj Pharmaceuticals Business Overview
7.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
7.5.5 Taj Pharmaceuticals Recent Developments
7.6 Xeris Pharmaceuticals
7.6.1 Xeris Pharmaceuticals Comapny Information
7.6.2 Xeris Pharmaceuticals Business Overview
7.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
7.6.5 Xeris Pharmaceuticals Recent Developments
8 NORTH AMERICA
8.1 North America Glucagon Market Size by Type
8.1.1 North America Glucagon Revenue by Type (2019-2030)
8.1.2 North America Glucagon Sales by Type (2019-2030)
8.1.3 North America Glucagon Price by Type (2019-2030)
8.2 North America Glucagon Market Size by Application
8.2.1 North America Glucagon Revenue by Application (2019-2030)
8.2.2 North America Glucagon Sales by Application (2019-2030)
8.2.3 North America Glucagon Price by Application (2019-2030)
8.3 North America Glucagon Market Size by Country
8.3.1 North America Glucagon Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Glucagon Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Glucagon Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Glucagon Market Size by Type
9.1.1 Europe Glucagon Revenue by Type (2019-2030)
9.1.2 Europe Glucagon Sales by Type (2019-2030)
9.1.3 Europe Glucagon Price by Type (2019-2030)
9.2 Europe Glucagon Market Size by Application
9.2.1 Europe Glucagon Revenue by Application (2019-2030)
9.2.2 Europe Glucagon Sales by Application (2019-2030)
9.2.3 Europe Glucagon Price by Application (2019-2030)
9.3 Europe Glucagon Market Size by Country
9.3.1 Europe Glucagon Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Glucagon Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Glucagon Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Glucagon Market Size by Type
10.1.1 China Glucagon Revenue by Type (2019-2030)
10.1.2 China Glucagon Sales by Type (2019-2030)
10.1.3 China Glucagon Price by Type (2019-2030)
10.2 China Glucagon Market Size by Application
10.2.1 China Glucagon Revenue by Application (2019-2030)
10.2.2 China Glucagon Sales by Application (2019-2030)
10.2.3 China Glucagon Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Glucagon Market Size by Type
11.1.1 Asia Glucagon Revenue by Type (2019-2030)
11.1.2 Asia Glucagon Sales by Type (2019-2030)
11.1.3 Asia Glucagon Price by Type (2019-2030)
11.2 Asia Glucagon Market Size by Application
11.2.1 Asia Glucagon Revenue by Application (2019-2030)
11.2.2 Asia Glucagon Sales by Application (2019-2030)
11.2.3 Asia Glucagon Price by Application (2019-2030)
11.3 Asia Glucagon Market Size by Country
11.3.1 Asia Glucagon Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Glucagon Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Glucagon Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Glucagon Market Size by Type
12.1.1 MEALA Glucagon Revenue by Type (2019-2030)
12.1.2 MEALA Glucagon Sales by Type (2019-2030)
12.1.3 MEALA Glucagon Price by Type (2019-2030)
12.2 MEALA Glucagon Market Size by Application
12.2.1 MEALA Glucagon Revenue by Application (2019-2030)
12.2.2 MEALA Glucagon Sales by Application (2019-2030)
12.2.3 MEALA Glucagon Price by Application (2019-2030)
12.3 MEALA Glucagon Market Size by Country
12.3.1 MEALA Glucagon Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Glucagon Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Glucagon Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Glucagon Value Chain Analysis
13.1.1 Glucagon Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Glucagon Production Mode & Process
13.2 Glucagon Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Glucagon Distributors
13.2.3 Glucagon Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
